Omega-3 (EPA+DHA)
Other trackedYour intake
What each level of omega-3 (epa+dha) does
Approximate dose-response bands. Individual response varies — these are starting points, not prescriptions.
- Severely lowYOU ARE HERE0 mg – 165 mg
EPA + DHA contribution to cell membranes, mood, and cardiovascular function compromised.
- Insufficient165 mg – 500 mg
Most Western diets are below the AHA-suggested 500 mg/day baseline.
- Adequate500 mg – 750 mg
AHA baseline (500 mg EPA+DHA) met. Good for general cardiovascular maintenance.
- Therapeutic750 mg – 1000 mg
2–4 g/day used for triglyceride lowering and inflammation. Look for triglyceride-form or rTG products.
- Diminishing returns1000 mg – +
Bleeding risk at very high doses, especially with anticoagulants.
Overview
Family of polyunsaturated fatty acids: ALA (alpha-linolenic acid, plant) is the essential parent; EPA and DHA (marine) are the metabolically active long-chain forms with the strongest evidence base. Cardiovascular, neurological, and anti-inflammatory effects are well-documented; vegetarian conversion of ALA → EPA/DHA is poor (~5–10%).
Functions
- ●Structural component of cell membranes (especially neural and retinal)
- ●Substrate for anti-inflammatory eicosanoids (resolvins, protectins, maresins)
- ●Modulates cardiac electrical stability and triglyceride synthesis
- ●Required for normal fetal neural and visual development (DHA)
- ●Regulates gene expression via PPAR transcription factors
Mechanism
EPA and DHA incorporate into cell membrane phospholipids, displacing arachidonic acid. Membrane EPA serves as substrate for less inflammatory series-3 prostaglandins, series-5 leukotrienes, and the resolvins/protectins/maresins that actively terminate inflammation. DHA-rich membranes (retina, brain grey matter) support fluidity and ion-channel function. Hepatic triglyceride lowering is via reduced VLDL secretion and increased fatty acid beta-oxidation.
Benefits
- ●Lowers triglycerides (~25–30% at 2–4 g EPA+DHA daily)
- ●Reduces sudden cardiac death and major adverse CV events (REDUCE-IT with icosapent ethyl)
- ●Reduces rheumatoid arthritis joint tenderness
- ●Modest reduction in mild-to-moderate depression (EPA-dominant formulas)
- ●Supports fetal brain and visual development (DHA in pregnancy)
- ●May reduce dry eye symptoms
Deficiency
Frank essential fatty acid deficiency is rare. Functional inadequacy is widespread — Omega-3 Index (RBC EPA+DHA % of total fatty acids) <4% associates with increased CV risk; most Western diets sit at 4–5%, ideal target ~8–11%.
- ●Dry skin, eczema-like patches
- ●Poor wound healing
- ●Visual changes (retinal DHA depletion)
- ●Cognitive symptoms, low mood
- ●Increased CV risk markers
- ●Strict vegan diets without algae oil
- ●Low fish consumption (most Western populations)
- ●Premature infants
- ●Cystic fibrosis, fat malabsorption
Excess
FDA GRAS up to 3 g/day from supplements (excluding diet). Higher doses (4 g+) modestly increase bleeding time and AFib incidence in REDUCE-IT and STRENGTH.
- ●Increased bleeding tendency (especially with anticoagulants)
- ●Fishy burps / GI upset
- ●Modestly increased AFib at very high doses
- ●Possible LDL increase with high-dose DHA
Forms
- Triglyceride (TG) fish oilNatural form; ~50% better absorbed than ethyl ester
- Re-esterified triglyceride (rTG)Concentrated and re-converted to TG form; high bioavailability
- Ethyl ester (EE)Cheaper concentrate; lower bioavailability; needs higher dose
- Phospholipid (krill oil)Better-absorbed at low doses; expensive per mg EPA+DHA
- Algae oil (vegan DHA/EPA)Direct source, bypasses ALA conversion; the vegan option
- Icosapent ethyl (Vascepa)Rx-grade pure EPA EE; the REDUCE-IT trial molecule
Food sources
- Wild salmon (cooked) · 3 oz1,800 mg EPA+DHA
- Sardines (canned) · 3 oz1,200 mg EPA+DHA
- Mackerel (cooked) · 3 oz2,500 mg EPA+DHA
- Anchovies (canned) · 2 oz1,000 mg EPA+DHA
- Algae oil supplement · 1 capsule300–500 mg DHA
- Ground flaxseed · 1 tbsp2,300 mg ALA (~115 mg net EPA equivalent)
Supplement forms
Triglyceride or re-esterified triglyceride (rTG) forms absorb better than ethyl ester (EE) forms. Look for products that specify EPA and DHA content per serving — total 'fish oil' mg is misleading. 1–2 g EPA+DHA daily is the typical maintenance dose. For vegan, algae-derived DHA (often paired with EPA) is the only direct route. Take with a fat-containing meal.
Bioavailability
TG form ~50% better absorbed than EE; rTG and krill oil also high. Take with a fat-containing meal (raises absorption 2–4×). Fishy burps are usually a quality (oxidation) issue — check that the product has an antioxidant (vitamin E, rosemary) and isn't past expiration. Refrigerate after opening.
Longevity relevance
Strong observational signal: higher Omega-3 Index correlates with lower all-cause and CV mortality. EPA-dominant icosapent ethyl reduced major adverse CV events 25% in REDUCE-IT. DHA supports brain structure across life. Among the cleanest cases for routine supplementation in low-fish populations.
Relationships
- Vitamin E · Protects PUFAs from peroxidation; co-formulated in most fish oils
- Astaxanthin · Carotenoid antioxidant; pairs with omega-3 for membrane protection
- Vitamin D, K2 · Common combined cardiometabolic supplement
- Warfarin / antiplatelet drugs · Additive bleeding risk at >3 g/day EPA+DHA
- Omega-6 PUFAs (very high) · Compete for desaturase enzymes; ratio matters more than absolute intake
References
About Omega-3 (EPA+DHA)
EPA+DHA — anti-inflammatory, cardiovascular, brain membrane. Target reflects common AHA/NIH guidance (no FDA DV).
- Role
- Cardio · brain
- Daily target
- 500 mg (TR)
- Also called
- omega-3, omega 3, epa, dha, epa+dha, fish oil
The mechanisms and systems this nutrient feeds. Click any to drill into what runs on it.
★ = load-bearing / primary cofactor. Track these in My Journey.